Abstract
To combat the escalating issue of antibiotic-resistant infections and the slow pace of new chemical drug development relative to the rapid evolution of bacteria, it is crucial to explore novel therapeutic approaches such as bioactive peptides. In this study, a new peptide sequence was identified from the skin secretion of Pelophylax nigromaculatus by obtaining the cDNA through molecular cloning and then analysing the cDNA sequence using bioinformatics tools. The peptide was then synthesised using solid-phase peptide synthesis (SPPS) and purified by high-performance liquid chromatography (HPLC). Its biological activity and toxicity were evaluated through antibacterial assays, haemolysis tests, and MTT assays. The results showed that QUB-3028 exhibited strong antibacterial activity against S. aureus NCTC 10788, E. coli NCTC 10418 with a MIC value of 2 µM, and moderate antimicrobial activity against C. albicans ATCC 10231 with a MIC value of 32 µM. It was also potent against human adenocarcinoma cell line NCI-H838 in the MTT assay with a IC50 value of 4.6 µM, while demonstrating 25% haemolytic activity at the concentration of 128 µM. Therefore, QUB-3028 has strong antibacterial and antiproliferative activities, with its effective concentration for biological activity being much lower than that required to induce haemolytic activity. QUB-3028 may be a promising candidate for the preclinical screening of drugs against drug-resistant infections and anti-tumour drugs.Thesis is embargoed until 31 December 2029.
Date of Award | Dec 2024 |
---|---|
Original language | English |
Awarding Institution |
|
Supervisor | Lei Wang (Supervisor), Tianbao Chen (Supervisor) & Mei Zhou (Supervisor) |
Keywords
- antimicrobial peptides
- amphibian skin secretions
- Molecular cloning
- ranatuerin-2
- preclinical screening